Retrovirus agents MSRV1 and MSRV2 associated with multiple scler

Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4242071, 4241301, 4241591, 4241871, 4242041, 4241851, 4242151, 4241861, 536 2372, 536 243, C12N 700, A61K 3912, A61K 39395, A61K 3921

Patent

active

058719962

ABSTRACT:
Composition including two pathogenic and/or infective agents associated with multiple sclerosis, namely a first agent which consists of a human virus possessing reverse transcriptase activity and related to a family of endogenous retroviral elements, or a variant of the virus, and a second agent, or a variant of the second agent, these two pathogenic and/or infective agents originating from the same viral strain chosen from the strains designated, respectively, POL-2 deposited with the ECACC on Jul. 22, 1992 under Accession Number V92072202 and MS7PG deposited with the ECACC on Jan. 8, 1993 under Accession Number V93010816, and from their variant strains.

REFERENCES:
patent: 4311686 (1982-01-01), Angers et al.
patent: 4346074 (1982-08-01), Gilmour et al.
patent: 4388298 (1983-06-01), Nazerian et al.
patent: 4396600 (1983-08-01), Messineo et al.
patent: 4520113 (1985-05-01), Gallo et al.
patent: 4647773 (1987-03-01), Gallo et al.
patent: 4708818 (1987-11-01), Montagnier et al.
patent: 4900553 (1990-02-01), Silver et al.
patent: 5158976 (1992-10-01), Rosenburg et al.
patent: 5219837 (1993-06-01), Cohen et al.
patent: 5225352 (1993-07-01), Zanetta et al.
patent: 5585262 (1996-12-01), Perron et al.
Sommerland, et al., 1993, Acta Neurol Scand, vol. 87, pp. 71-76.
Boswell, et al., 1988, Oxford Univ. Press, Chapt. 14 pp. 161-178. (Computational Molecular Biology).
S. Haahr et al., "Is Multiple Sclerosis Caused by a Dual Infection with Retrovirus and Epstein-Barr Virus?", Neuroepidemiology, vol. 11, pp. 299-303, (1992).
G. La Mantia et al., "Identification of New Human Repetitive Sequences: Characterization of the Corresponding cDNAs and their Expresion in Embryonal Carcinoma Cells", Nucleic Acids Research, vol. 17, No. 15, 5913-5922, (1989).
J. Merregaert et al., "Nucleotide Sequence of a Radiation Leukemia Virus Genome", Virology, vol. 158, No. 1, pp. 88-102, (1987).
Acha-Orbea et al., "Mls--A Retrovirus Exploits the Immune System", Immunology Today, vol. 12, No. 10, 1991, pp. 356-361.
Asai et al., "J. of Neurochem", vol. 59, No. 1, pp. 307-317, 1992.
ATCC Catalogue of Cell Lines and Hybridomas, Sixth Edition, 1988, pp. 165 and 344-355.
C.R.M. Bangham et al., "PCR Analysis of DNA from Multiple Sclerosis Patients for the Presence of HTLV-I", Science, vol. 246, Nov. 10, 1989, pp. 821-824.
R. Baccala et al., "Genomically Imposed and Somatically Modified Human Thymocyte vb Gene Repertoires", Proc. Natl. Acad. Sci., vol. 88, pp. 2908, 1991.
Barna et al., "Human Astrocytes Proliferate in Response to Tumor Necrosis Factor Alpha", J. Neuroimmunol., 30 (1990), pp. 239-243.
Beck et al., "Increased Production of Interferon Gamma and Tumor Necrosis Factor Precedes Clinical Manifestation in Multiple Sclerosis: Do Cytokines Trigger Off Exacerbations?", Acta Neurol. Scand., 1988: 78, pp. 318-323.
Bergamini et al., "Multiple Sclerosis. I. The Immune Pathogenetic Hypothesis", Riv. Neurol., vol. 59, No. 5, Oct. 1989, pp. 176-190.
T. Bergstrom et al., "Isolation of Herpes Virus Type 1 During First Attack of Multiple Sclerosis.", Annales Neurology, vol. 26, pp. 283-285, (1989).
Bernton et al., "No Direct Neuronotoxicity by HIV-1 Virions or Culture Fluids from HIV-1 Infected T Cells or Monocytes", Aids Research and Human Retroviruses, vol. 8, No. 4, 1992, pp. 495-503.
Birnbaum et al., "Spinal Fluid Lymphocytes from a SubGroup of Multiple Sclerosis Patients Respond to Mycobacterial Antigens", Ann. Neurol., vol. 34, No. 1, Jul. 1993, pp. 18-24.
Bjare, "Serum-Free Cell Culture", Pharmac. Ther., vol. 53, 1992, pp. 355-374.
C. Bosgiraud et al., "Ultrastructural Study on Visna Virus in Sheep Plexus Choroid Cells", Biological Abstracts, vol. 83, No. 7, 1987.
Boyle et al., "Cellular Immune Response in Multiple Sclerosis Plaques", American Journal of Pathology, vol. 137, No. 3, Sep. 1990, pp. 575-584.
Bradford, A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding, Anal. Biochem., 72, 1976, pp. 248-254.
Brocke et al., "Induction of Relapsing Paralysis in Experimental Autoimmune Encephalomyelitis by Bacterial Superantigen", Nature, vol. 365, Oct. 14, 1993, pp. 642-644.
Calder, et al., "MS: A Localized Immune Disease of the Central Nervous System", Immunology Today, vol. 10, No. 3, 1989, pp. 99-103.
Carp et al., "Viral Etiology of Multiple Sclerosis", Prog. Med. Virol., vol. 24, pp. 158-177, 1978. Sclerosis!", Gaz. Hop. (Paris), 1868; 41, 554-66.
Cole et al., "The Mycoplasma Arthritidis T-Cell Mitogen, MAM: A Model Superantigen", Immunology Today, vol. 12, No. 8, 1991, pp. 271-276.
Dalgleish et al., "Do Human T-Lymphotrophic Viruses (HTLVs) and Other Enveloped Viruses Induce Autoimmunity in Multiple Sclerosis?", Neuropath. App. Neurobiol., 1987, 13, pp. 241-250.
A. N. Davison et al., "Biosynthesis of Myelin and Neurotoxic Factors in the Serum of Multiple Sclerosis Patients", Advances in Experimental Medicine and Biology, vol. 100, pp. 19-25, 1978.
De Keyser, "Autoimmunity in Multiple Sclerosis", Neurology, 38, Mar. 1988, pp. 371-374.
S. Dhib-Jalbut et al., "Measles Virus Polypeptide-Specific Antibody Profile in Multiple Sclerosis", Neurology, vol. 40, pp. 430-435, (1990).
Ebers et al., "The Geography of MS Reflects Genetic Susceptibility", Neurology, 36, Apr. 1986, Suppl. 1, p. 108.
Escourolle et al., "Principales Donnees Morphologiques Approches Morphological Data, Physiopathological and Etiological Approaches to Multiple Sclerosis!", La Reveue du Praticien, Paris, 1980; 30, pp. 2047-2053.
E. J. Field, "Immunological Treatment for Multiple Sclerosis", The Lancet, Jun. 3, 1989, p. 1272.
Medline Absract of FU et al., "Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine," Proc Natl Acad Sci USA 88: 2001-05 (1991).
Galiana et al., "Establishment of Permanent Astroglial Cell Lines, Able to Differentiate in Vitro, From Transgenic Mice Carrying the Polyoma Virus Large T Gene: An Alternative Approach to Brain Cell Immortalization", Journal of Neuroscience Research, 1990; 26: pp. 269-277.
M. B. Gardner et al., "Congenital Transmission of Murine Leukaemia Virus from Wild Mice Prone to Development of Lymphoma and Paralysis", J. Natl. Cancer Inst., vol. 62, pp. 63-69, (1979).
M. B. Gardner, "Genetic resistance to a Retroviral Neurologic Disease in Wild Mice, in Retrovirus Infections of the Nervous System", Oldstone M.B.A. and Koprowsky H. Eds. Current Topice in Microbiology and Immunology, No. 160, pp. 3-10, (Springer-Verlag, Berlin, 1990).
Gay, "Is Multiple Sclerosis Caused by an Oral Spirochaete", The Lancet, Jul. 12, 1986, pp. 75-77.
A. Gessain et al., Antibodies to Human T-Lymphotrophic Virus type-I in Patients with Tropical Spastic Paraparesis, Lancet, vol. 2, pp. 407-410, (1985).
Giulian et al., "The Envelope Glycoprotein of Human Immunodeficiency Virus Type 1 Stimulates Release of Neurotoxins from Monocytes", Proc. Natl. Acad. Sci. USA, vol. 90, 1993, pp. 2769-2773.
D. Giulian et al., "Secretion of Neurotoxins by Mononuclear Phagocytes Infected with HIV-1", Science, vol. 250, Dec. 14, 1990, pp. 1593-1596.
Gonzalez-Scarano et al., "Multiple Sclerosis Disease Activity Correlates with Gadolinium-Enhanced Magnetic Resonance Imaging", Annals of Neurology, vol. 21, No. 3, Mar. 1987, pp. 300-306.
F. Gonzalez-Scarano et al., "Sequence Similarities Between Human Immunodeficiency Virus gp41 and Paramyxovirus Fusion Proteins.", AIDS Res. Hum. Retrov., vol. 3, pp. 245-252, (1987).
S. Haahr et al., "A Putative New Retrovirus Associated with Multiple Sclerosis and the Possible Involvement of Epstein-Barr Virus in this Disease", NY Acad. Science, vol. 724, pp. 148-156, 1994.
S. Haahr et al., "Just Another Dubious Virus in Cells from a Patient with Multiple Sclerosis?", The Lancet, vol. 337, Apr. 6, 1991, pp. 863-864.
A. T. Haase, "Pathogenesis of Lentivirus Infections", Nature, vol. 322, Jul. 10, 1986, pp. 130-136.
Haegert et al. HLA-DR.beta., -DQ.alpha., and -DQ.beta. Restriction Fragment Length Polymorphisms in Multiple Sclerosis, J. Neurosci. Res., 1989; 23, pp. 46-54.
Hauw et al., "Aspects Anatomo-Patholo

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Retrovirus agents MSRV1 and MSRV2 associated with multiple scler does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retrovirus agents MSRV1 and MSRV2 associated with multiple scler, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retrovirus agents MSRV1 and MSRV2 associated with multiple scler will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2061577

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.